IMARC Group, a leading market research company, has recently releases report titled “Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the market.

How Big is the Prostate Cancer Treatment Market?

The global prostate cancer treatment market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Industry Overview of Prostate Cancer Treatment

Prostate cancer treatment represents medical therapies and medications that are used to treat severe malignant tumors caused by the uncontrollable division and expansion of several abnormal cells in the prostate gland present in men. They consist of chemotherapy, biological therapy, hormone therapy, immunotherapy, cryotherapy, surgery, radiation therapy, etc. These prostate cancer treatment procedures are provided to the patients based on their age, types of symptoms, previous health history, etc. They aid in destroying cancer cells and reducing the severity of the diseases. Consequently, prostate cancer treatment methods and items are extensively utilized in hospitals and other healthcare establishments across the globe.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/prostate-cancer-treatment-market/requestsample

What are the growth prospects and trends in the prostate cancer treatment industry?

The elevating prevalence of prostate cancer, especially amongst the growing geriatric population, is primarily driving the prostate cancer treatment market. In addition to this, the increasing availability of favorable medical reimbursement plans and the launch of numerous policies by government bodies across countries aimed at introducing patient assistance programs (PAPs) are acting as significant growth-inducing factors.

Furthermore, the expanding technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with metastatic hormone nave (mHNPC) and non-metastatic castration-resistant (nmCRPC) settings to detect prostate cancer at early stages and mitigate diagnostic errors, is also positively influencing the global market.

Besides this, the rising research and development (RD) activities related to genomics and proteomics and the introduction of strong pipeline drugs are further stimulating the market growth. Moreover, the escalating availability of therapeutic products online and the development of novel cytotoxic medicines and anti-prostate-specific membrane antigen therapies are expected to propel the prostate cancer treatment market over the forecasted period.

Leading Companies Operating in the Global Prostate Cancer Treatment Industry:

• Astellas Pharma Inc.
• AstraZeneca plc
• Bayer Aktiengesellschaft
• Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
• F. Hoffmann-La Roche AG
• Ferring B.V.
• GlaxoSmithKline Plc
• Ipsen (Mayroy SA)
• Novartis International AG
• Takeda Pharmaceutical Company Ltd.
• Tolmar Pharmaceuticals Inc.

Prostate Cancer Treatment Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Drug Type:

• Chemotherapy
• Biological Therapy
• Hormone Therapy
• Others

Breakup by Distribution Channel:

• Hospitals Pharmacies
• Drug Stores and Retail Pharmacies
• Online Pharmacies

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163